lysine has been researched along with Hemorrhagic Thrombocythemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cooney, J; Hodges, S | 1 |
| Krecak, I; Lucijanic, M; Verstovsek, S | 1 |
| Hsiao, HH; Hsu, JF; Lee, CP; Lin, SF; Liu, YC; Tsai, HJ | 1 |
1 review(s) available for lysine and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia.
Topics: Anticoagulants; Biomarkers; Hepcidins; Histone Deacetylase Inhibitors; Humans; Interferons; Lysine; Nitriles; Polycythemia Vera; Pyrazoles; Pyrimidines; Quality of Life; Risk Assessment; Telomerase; Thrombocythemia, Essential; Thrombosis; Venous Thromboembolism; Warfarin | 2022 |
2 other study(ies) available for lysine and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Novel lysine-specific histone demethylase 1 inhibitor in acute myeloid leukaemia transformed from essential thrombocythaemia.
Topics: Aged; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia, Myeloid, Acute; Lysine; Thrombocythemia, Essential | 2022 |
JAK2V617F mutation is associated with special alleles in essential thrombocythemia.
Topics: Alleles; Amino Acid Substitution; DNA Mutational Analysis; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Humans; Janus Kinase 2; Leucine; Lysine; Mutation, Missense; Phenylalanine; Polymorphism, Single Nucleotide; Receptors, Thrombopoietin; Thrombocythemia, Essential; Tryptophan; Valine | 2011 |